Akums gets DCGI approval to launch Lobeglitazone for diabetes treatment in India EP News Bureau Feb 6, 2023 It offers a number of advantages including a higher safety profile, higher effectiveness in lower dosage, lower risk of…
US FDA approves first generic glucagon injection to treat severe hypoglycaemia EP News Bureau Dec 29, 2020 The FDA granted this approval to Amphastar Pharmaceuticals of Rancho Cucamonga, California
